ETHINYLESTRADIOL prosate cancer Archives - Gpatindia: Pharmacy Jobs, Admissions, Scholarships, Conference,Grants, Exam Alerts

ETHINYLESTRADIOL Synthesis, SAR, MCQ,Structure,Chemical Properties and Therapeutic Uses

February 25, 2020February 25, 2020 huzefakifayet GPAT Preparation, MCQ, NIPER JEE Examination (Masters/Ph.D. Admission), Pharmacy Exam Questions, Quiz, Study Material ETHINYLESTRADIOL, ETHINYLESTRADIOL breast cancer, ETHINYLESTRADIOL chemical properties, ETHINYLESTRADIOL contraceptive, ETHINYLESTRADIOL feminizing hormone, ETHINYLESTRADIOL gpat questions, ETHINYLESTRADIOL gpatindia, ETHINYLESTRADIOL hypogonadism, ETHINYLESTRADIOL mechanism of action, ETHINYLESTRADIOL menopausal hormone therapy, ETHINYLESTRADIOL osteoporosis, ETHINYLESTRADIOL physical properties, ETHINYLESTRADIOL prosate cancer, ETHINYLESTRADIOL SAR, ETHINYLESTRADIOL side effects, ETHINYLESTRADIOL structure, ETHINYLESTRADIOL synthesis, ETHINYLESTRADIOL therapeutic uses, gpatindia Leave a comment

Ethinylestradiol IUPAC nomenclature (8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol. Classification Ethinylestradiol is classified as an estrogen drug, altering the hormonal milieu. [1] Physiochemical Properties S. NO. PHYSICAL AND CHEMICAL PROPERTIES 1 Molecular weight 296.4 g/mol 2 Appearance White to creamy white powder 3 Melting point […]

0 items - ₹0.00 in cart

Cart

Tag: ETHINYLESTRADIOL prosate cancer

ETHINYLESTRADIOL Synthesis, SAR, MCQ,Structure,Chemical Properties and Therapeutic Uses